Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(2.03)
# 1,508
Out of 4,479 analysts
51
Total ratings
41.18%
Success rate
-9.05%
Average return
Main Sectors:
Top Industries:
6 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HOWL Werewolf Therapeutics | Reiterates: Buy | $15 | $2.35 | +538.30% | 13 | Jun 26, 2024 | |
| SRRK Scholar Rock Holding | Reiterates: Buy | $30 | $8.13 | +269.00% | 10 | Jun 25, 2024 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $40 | $13.58 | +194.55% | 9 | Jun 20, 2024 | |
| IKNA Ikena Oncology | Maintains: Buy | $11 → $4 | $1.65 | +142.42% | 9 | May 29, 2024 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $31.72 | +136.44% | 5 | May 28, 2024 | |
| ERAS Erasca | Maintains: Buy | $8 → $5 | $2.44 | +104.92% | 5 | May 20, 2024 |
Werewolf Therapeutics
Jun 26, 2024
Reiterates: Buy
Price Target: $15
Current: $2.35
Upside: +538.30%
Scholar Rock Holding
Jun 25, 2024
Reiterates: Buy
Price Target: $30
Current: $8.13
Upside: +269.00%
Day One Biopharmaceuticals
Jun 20, 2024
Reiterates: Buy
Price Target: $40
Current: $13.58
Upside: +194.55%
Ikena Oncology
May 29, 2024
Maintains: Buy
Price Target: $11 → $4
Current: $1.65
Upside: +142.42%
CG Oncology
May 28, 2024
Reiterates: Buy
Price Target: $75
Current: $31.72
Upside: +136.44%
Erasca
May 20, 2024
Maintains: Buy
Price Target: $8 → $5
Current: $2.44
Upside: +104.92%